ChEMBL ID: CHEMBL1201827
Mechanism of action: Epidermal growth factor receptor erbB1 inhibitor
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Trials and conditions connected to PANITUMUMAB